Receptor Activator of Nuclear Factor κB Ligand Is a Novel Inducer of Tissue Factor in Macrophages
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 107 (7) , 871-876
Abstract
Rationale: Although recent studies have suggested a role for the receptor activator of nuclear factor κB ligand (RANKL) in the late stages of atherosclerosis (eg, plaque destabilization and rupture), the underlying mechanisms and subsequent events are unclear. Objective: Because blood clotting is common after plaque rupture, we hypothesized that RANKL influenced tissue factor (TF) expression and activity to initiate the coagulation cascade. Methods and Results: RANKL increased the TF mRNA level and procoagulant activity in macrophages, as determined by semiquantitative reverse transcription polymerase chain reaction (semiquantitative RT-PCR) and a chromogenic assay. TF promoter analysis revealed that AP-1 and Egr-1 are responsible for RANKL-induced TF transcription. In addition, RANKL increased phosphorylation of c-Jun NH2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)1/2. RANKL-induced TF expression was attenuated by JNK- and MEK1-specific inhibitors and by small interfering RNA knockdown of c-Jun and Egr-1. Conclusion: Our results indicate that RANKL induces TF in macrophages mainly through the cooperative action of AP-1 and Egr-1 via JNK and ERK1/2 pathways. These findings provide strong mechanistic support for the role of RANKL in the thrombogenicity of atherosclerotic plaques.Keywords
This publication has 15 references indexed in Scilit:
- RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent PathwayCirculation Research, 2009
- Imaging of atherosclerotic cardiovascular diseaseNature, 2008
- Triggers, targets and treatments for thrombosisNature, 2008
- Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Cardiovascular DiseaseCirculation, 2007
- Receptor activator of nuclear factor (NF)–κB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient miceBlood, 2006
- Enhanced T-Cell Expression of RANK Ligand in Acute Coronary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Tissue Factor in Cardiovascular DiseasesCirculation, 2006
- TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial CellsThe Journal of Immunology, 2005
- Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OsteoprotegerinCirculation Research, 2004
- Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic proteinNature Medicine, 2003